These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29947472)

  • 1. Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review.
    Boteon YL; Boteon APCS; Attard J; Mergental H; Mirza DF; Bhogal RH; Afford SC
    Am J Transplant; 2018 Oct; 18(10):2384-2399. PubMed ID: 29947472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study.
    Abbas SH; Ceresa CDL; Hodson L; Nasralla D; Watson CJE; Mergental H; Coussios C; Kaloyirou F; Brusby K; Mora A; Thomas H; Kounali D; Keen K; Pollok JM; Gaurav R; Iype S; Jassem W; Perera MTP; Hakeem AR; Knight S; Friend PJ
    Trials; 2024 Jun; 25(1):386. PubMed ID: 38886851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content.
    Raigani S; Carroll C; Griffith S; Pendexter C; Rosales I; Deirawan H; Beydoun R; Yarmush M; Uygun K; Yeh H
    PLoS One; 2020; 15(5):e0232886. PubMed ID: 32396553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatotic Donor Transplant Livers: Preservation Strategies to Mitigate against Ischaemia-Reperfusion Injury.
    Abbas SH; Ceresa CDL; Pollok JM
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.
    Resch T; Cardini B; Oberhuber R; Weissenbacher A; Dumfarth J; Krapf C; Boesmueller C; Oefner D; Grimm M; Schneeberger S
    Front Immunol; 2020; 11():631. PubMed ID: 32477321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery.
    Boteon YL; Attard J; Boteon APCS; Wallace L; Reynolds G; Hubscher S; Mirza DF; Mergental H; Bhogal RH; Afford SC
    Liver Transpl; 2019 Jul; 25(7):1007-1022. PubMed ID: 30821045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defatting of Human Livers During Long-Term e x situ Normothermic Perfusion: Novel Strategy to Rescue Discarded Organs for Transplantation.
    Sousa Da Silva RX; Bautista Borrego L; Lenggenhager D; Huwyler F; Binz J; Mancina L; Breuer E; Wernlé K; Hefti M; Mueller M; Cunningham L; De Oliveira ML; Petrowsky H; Weber A; Dutkowski P; Hoffmann W; Gupta A; Tibbitt MW; Humar B; Clavien PA
    Ann Surg; 2023 Nov; 278(5):669-675. PubMed ID: 37497663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological agents for defatting livers by normothermic machine perfusion.
    Li SX; Chen L; Li MQ; Lv GY
    Artif Organs; 2023 Jun; 47(6):925-933. PubMed ID: 36514256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine perfusion of the liver: applications in transplantation and beyond.
    Ceresa CDL; Nasralla D; Pollok JM; Friend PJ
    Nat Rev Gastroenterol Hepatol; 2022 Mar; 19(3):199-209. PubMed ID: 34997204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft repair during machine perfusion: a current overview of strategies.
    Broere R; Luijmes SH; de Jonge J; Porte RJ
    Curr Opin Organ Transplant; 2024 Aug; 29(4):248-254. PubMed ID: 38726753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Subnormothermic Machine Perfusion Preservation in Severely Steatotic Rat Livers: A Detailed Assessment in an Isolated Setting.
    Okamura Y; Hata K; Tanaka H; Hirao H; Kubota T; Inamoto O; Kageyama S; Tamaki I; Yermek N; Yoshikawa J; Uemoto S
    Am J Transplant; 2017 May; 17(5):1204-1215. PubMed ID: 27860296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making Every Liver Count: Increased Transplant Yield of Donor Livers Through Normothermic Machine Perfusion.
    MacConmara M; Hanish SI; Hwang CS; De Gregorio L; Desai DM; Feizpour CA; Tanriover B; Markmann JF; Zeh H; Vagefi PA
    Ann Surg; 2020 Sep; 272(3):397-401. PubMed ID: 32694447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers.
    van Leeuwen OB; Bodewes SB; Lantinga VA; Haring MPD; Thorne AM; Brüggenwirth IMA; van den Berg AP; de Boer MT; de Jong IEM; de Kleine RHJ; Lascaris B; Nijsten MWN; Reyntjens KMEM; de Meijer VE; Porte RJ
    Am J Transplant; 2022 Jun; 22(6):1658-1670. PubMed ID: 35286759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normothermic liver machine perfusion as a dynamic platform for regenerative purposes: What does the future have in store for us?
    Lascaris B; de Meijer VE; Porte RJ
    J Hepatol; 2022 Sep; 77(3):825-836. PubMed ID: 35533801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
    Jamieson RW; Zilvetti M; Roy D; Hughes D; Morovat A; Coussios CC; Friend PJ
    Transplantation; 2011 Aug; 92(3):289-95. PubMed ID: 21681143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using organ perfusion to optimize donor livers.
    Lee-Riddle GS; Panayotova GG; Guarrera JV
    Curr Opin Organ Transplant; 2023 Apr; 28(2):95-103. PubMed ID: 36752282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of machine perfusion in livers showing steatosis prior to transplantation: a systematic review.
    Lai Q; Ruberto F; Pawlik TM; Pugliese F; Rossi M
    Updates Surg; 2020 Sep; 72(3):595-604. PubMed ID: 32449031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers.
    Banan B; Watson R; Xu M; Lin Y; Chapman W
    Liver Transpl; 2016 Jul; 22(7):979-93. PubMed ID: 27027254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial.
    Markmann JF; Abouljoud MS; Ghobrial RM; Bhati CS; Pelletier SJ; Lu AD; Ottmann S; Klair T; Eymard C; Roll GR; Magliocca J; Pruett TL; Reyes J; Black SM; Marsh CL; Schnickel G; Kinkhabwala M; Florman SS; Merani S; Demetris AJ; Kimura S; Rizzari M; Saharia A; Levy M; Agarwal A; Cigarroa FG; Eason JD; Syed S; Washburn WK; Parekh J; Moon J; Maskin A; Yeh H; Vagefi PA; MacConmara MP
    JAMA Surg; 2022 Mar; 157(3):189-198. PubMed ID: 34985503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies.
    Raigani S; Karimian N; Huang V; Zhang AM; Beijert I; Geerts S; Nagpal S; Hafiz EOA; Fontan FM; Aburawi MM; Mahboub P; Markmann JF; Porte RJ; Uygun K; Yarmush M; Yeh H
    PLoS One; 2020; 15(1):e0228011. PubMed ID: 31978172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.